Back to Studies

P1085 / Human Papilloma Virus (HPV) Type-Specific Antibody

Duration of Human Papilloma Virus (HPV) Type-Specific Antibody After Administration of Quadrivalent HPV Vaccine to HIV-infected Children

Study Status


DAIDS Number


IND Number

non-IND study

Clinical Trials Link


P1085 is a follow up study of participants enrolled in P1047 to determine the long term immunogenicity of quadrivalent HPV (QHPV) vaccine in HIV-1 infected children.  The study is designed to determine the HPV-type specific antibody levels at 2, 3.5, and 5 years after completion of the QHPV vaccine schedule and compare these to published levels of QHPV-induced antibody levels of HIV uninfected children.

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...